ME/CFS

EQS-News: Berlin Cures Expands Research Capabilities and Scientific Expertise with New Advisory Board

Retrieved on: 
Wednesday, April 10, 2024

Berlin, Germany, 3 April 2024 – Berlin Cures, a biotechnology company in Phase II clinical trial for a treatment against Long COVID, appoints six distinguished scientists to a new advisory board.

Key Points: 
  • Berlin, Germany, 3 April 2024 – Berlin Cures, a biotechnology company in Phase II clinical trial for a treatment against Long COVID, appoints six distinguished scientists to a new advisory board.
  • The aim of the board is to advise on industry developments and new growth potentials, as well as to support research and development that will further strengthen the portfolio of Berlin Cures and thus the successful market launch of new therapies.
  • “We are very pleased to now work with six renowned scientists who have achieved great success in their respective fields of research.
  • Berlin Cures has been known for innovative and effective research for years.

AIM ImmunoTech Bolsters Intellectual Property Estate for Ampligen® with Issuance of Two Key U.S. Patents

Retrieved on: 
Tuesday, November 28, 2023

OCALA, Fla., Nov. 28, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the U.S. Patent and Trademark Office (USPTO) has issued U.S. patent No. 11,813,279 and 11,813,281 for Ampligen® titled “Compositions for cancer therapy and methods,” and “Methods for improving exercise tolerance in myalgic encephalomyelitis patients,” respectively.

Key Points: 
  • 11,813,279 and 11,813,281 for Ampligen® titled “Compositions for cancer therapy and methods,” and “Methods for improving exercise tolerance in myalgic encephalomyelitis patients,” respectively.
  • AIM Chief Executive Officer Thomas K. Equels stated: “Our ongoing effort to expand and solidify AIM’s global intellectual property estate is a foundational component of our development strategy for Ampligen.
  • The combination of these compounds is designed to work synergistically to enhance the effectiveness of the treatment.
  • This exclusivity fortifies AIM's position in the market by enabling development of a distinctive and unparalleled treatment option.

AIM ImmunoTech Bolsters Intellectual Property Estate for Ampligen® with Issuance of Two Key U.S. Patents

Retrieved on: 
Monday, November 27, 2023

OCALA, Fla., Nov. 27, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the U.S. Patent and Trademark Office (USPTO) has issued U.S. patent No. 11,813,279 and 11,813,281 for Ampligen® titled “Compositions for cancer therapy and methods,” and “Methods for improving exercise tolerance in myalgic encephalomyelitis patients,” respectively.

Key Points: 
  • 11,813,279 and 11,813,281 for Ampligen® titled “Compositions for cancer therapy and methods,” and “Methods for improving exercise tolerance in myalgic encephalomyelitis patients,” respectively.
  • AIM Chief Executive Officer Thomas K. Equels stated: “Our ongoing effort to expand and solidify AIM’s global intellectual property estate is a foundational component of our development strategy for Ampligen.
  • The combination of these compounds is designed to work synergistically to enhance the effectiveness of the treatment.
  • This exclusivity fortifies AIM's position in the market by enabling development of a distinctive and unparalleled treatment option.

Solve Appoints Kristin Jacobson as President and Chief Executive Officer

Retrieved on: 
Monday, October 16, 2023

LOS ANGELES, Oct. 16, 2023 /PRNewswire/ -- Solve, a national non-profit organization leading research and advocacy for ME/CFS, Long Covid, and other post-infection diseases, is delighted to announce the appointment of Kristin Jacobson as its new President and Chief Executive Officer, effective October 16, 2023. Kristin succeeds Oved Amitay, who served as President and CEO from June 2020 to October 2023.

Key Points: 
  • Kristin succeeds Oved Amitay, who served as President and CEO from June 2020 to October 2023.
  • A passionate patient advocacy leader and a member of Solve's Board of Directors, Kristin Jacobson brings a wealth of experience and expertise to her new role.
  • Solve Board Chair John Nicols expressed his enthusiasm for Kristin's appointment, stating, "We are thrilled to have Kristin Jacobson take the helm as our new CEO.
  • As the incoming CEO, Kristin Jacobson is poised to lead Solve into an era of continued growth, innovation, and progress.

Scientists detail current evidence that Long COVID is caused by persistent SARS-CoV-2 viral reservoirs

Retrieved on: 
Thursday, September 7, 2023

The paper - written by 33 scientists - is titled "SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)."

Key Points: 
  • The paper - written by 33 scientists - is titled "SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)."
  • These reservoirs could be one of the primary drivers of the Long COVID disease process.
  • Importantly, the authors emphasize that antivirals or other drugs should be tested in clinical trials with the goal of clearing SARS-CoV-2 reservoirs in Long COVID patients.
  • Publication of the paper makes it clear that top researchers in the Long COVID space are taking SARS-CoV-2 persistence seriously.

Existential crisis: how long COVID patients helped us understand what it’s like to lose your sense of identity and purpose in life

Retrieved on: 
Thursday, August 24, 2023

Since contracting COVID in March 2020, Lucy told us she had been struggling with relentless fatigue, joint pain, breathlessness, brain fog and sensory dysfunction.

Key Points: 
  • Since contracting COVID in March 2020, Lucy told us she had been struggling with relentless fatigue, joint pain, breathlessness, brain fog and sensory dysfunction.
  • But worse than any single symptom is how this leaves her feeling about her own identity.
  • She said she found herself unrecognisable, a shadow of the person she used to be:
    This isn’t who I am – I don’t recognise myself.
  • My fear is I’ll never really get better, and that I’m always going to be at 70% of my former self.
  • It’s like I can’t picture myself any more in the same way [that I used to], on an upward trajectory.

Are existential crises common?

    • Strikingly, while sharing their experiences of living with these symptoms, more than half described a profound and, to them, often inexplicable anguish.
    • This emerged as they were forced to question their purpose, even their very existence, in the face of long COVID.
    • Yet there still appears to be only a limited understanding of the way that people experience full-on existential crisis – including among those family members and friends closest to them.
    • Existential crises can also centre around experiences such as a romantic break-up or bereavement, or even the global threats posed by climate change.

Losing your identity

    • The aftermath of their infection typically resulted in a wide range of symptoms affecting their breathing, heart and cognitive function.
    • I found it a little bit hard to adjust to – like I’d lost my identity slightly.
    • I found it a little bit hard to adjust to – like I’d lost my identity slightly.

Mourning the loss of physical capabilities

    • Drawing parallels between his loss and the amputation of a limb, Lewis suggested both experiences could result in a profound loss of identity in which “all sorts of pleasures and activities that I once took for granted will have to be simply written off”.
    • In this way, Lewis said, his “whole way of life will be changed”.
    • Their emotions were often raw and intense as they confronted not only loss of their former identity and lifestyle, but control of their body.
    • This may help explain how loss of control of the body can give rise to a form of grieving.
    • The painful aspect of grief arises from the ruptures it creates in our lives.

Fear of an uncertain future

    • Our participants faced daily struggles not only with the grief of losing their cherished past but fear of their uncertain future.
    • Life can be likened to the crafting of a book, with each scene gaining significance only when seen within the context of its broader narrative.
    • Finding coherence in our life stories is crucial to maintaining meaning and purpose, and building a buffer against the challenges of day-to-day life.
    • But for many, long COVID has disrupted this narrative, leading to a profound realisation of their vulnerability and mortality.

Suffering in silence

    • Many of our interviewees found it easier to articulate the surface-level challenges they faced, while struggling to convey the nuanced experiences of their deeper suffering.
    • In part, this may be because our society lacks the appropriate vocabulary to capture such profound and wide-ranging pain.
    • She felt there was “no point really talking about it as I could tell it’s upsetting for people to hear”.
    • John, 63, said he found it challenging to communicate his “hidden disability” and associated suffering because he was “not in a wheelchair” and didn’t have “a plaster cast on my hand”.
    • I had already taken a six-week sicknote and couldn’t take any more, because my financial position was very weak.

We need to talk about existential concerns

    • When considering coping strategies, we believe it is essential to promote a better understanding of the prevalence of existential crisis among society as a whole.
    • Not everyone, of course, can access highly specialised support such as existential therapy, which can be a useful tool for confronting existential dilemmas and gaining insight into values and beliefs.
    • What’s needed is a more accessible way to directly address and discuss our existential worries.
    • A European research project has created a programme to help healthcare professionals engage in existential conversations more sensitively and confidently.
    • *All names have been anonymised to protect the interviewees’ identities For you: more from our Insights series:
    • Chao Fang received funding from UKRI and NIHR (COV-LT-0009) for the study reported in this article.
    • JD Carpentieri received funding from UKRI and NIHR (COV-LT-0009) for the study reported in this article.

Existential crisis: how long COVID patients helped us understand what it’s like to lose all sense of identity and purpose in life

Retrieved on: 
Thursday, August 24, 2023

Since contracting COVID-19 in March 2020, Lucy told us she had been struggling with relentless fatigue, joint pain, breathlessness, brain fog and sensory dysfunction.

Key Points: 
  • Since contracting COVID-19 in March 2020, Lucy told us she had been struggling with relentless fatigue, joint pain, breathlessness, brain fog and sensory dysfunction.
  • But worse than any single symptom is how this leaves her feeling about her own identity.
  • She said she found herself unrecognisable, a shadow of the person she used to be:
    This isn’t who I am – I don’t recognise myself.
  • My fear is I’ll never really get better, and that I’m always going to be at 70% of my former self.
  • It’s like I can’t picture myself any more in the same way [that I used to], on an upward trajectory.

Are existential crises common?

    • Strikingly, while sharing their experiences of living with these symptoms, more than half described a profound and, to them, often inexplicable anguish.
    • This emerged as they were forced to question their purpose, even their very existence, in the face of long COVID.
    • Yet there still appears to be only a limited understanding of the way that people experience full-on existential crisis – including among those family members and friends closest to them.
    • Existential crises can also centre around experiences such as a romantic break-up or bereavement, or even the global threats posed by climate change.

Losing your identity

    • The aftermath of their infection typically resulted in a wide range of symptoms affecting their breathing, heart and cognitive function.
    • I found it a little bit hard to adjust to – like I’d lost my identity slightly.
    • I found it a little bit hard to adjust to – like I’d lost my identity slightly.

Mourning the loss of physical capabilities

    • Drawing parallels between his loss and the amputation of a limb, Lewis suggested both experiences could result in a profound loss of identity in which “all sorts of pleasures and activities that I once took for granted will have to be simply written off”.
    • In this way, Lewis said, his “whole way of life will be changed”.
    • Their emotions were often raw and intense as they confronted not only loss of their former identity and lifestyle, but control of their body.
    • This may help explain how loss of control of the body can give rise to a form of grieving.
    • The painful aspect of grief arises from the ruptures it creates in our lives.

Fear of an uncertain future

    • Our participants faced daily struggles not only with the grief of losing their cherished past but fear of their uncertain future.
    • Life can be likened to the crafting of a book, with each scene gaining significance only when seen within the context of its broader narrative.
    • Finding coherence in our life stories is crucial to maintaining meaning and purpose, and building a buffer against the challenges of day-to-day life.
    • But for many, long COVID has disrupted this narrative, leading to a profound realisation of their vulnerability and mortality.

Suffering in silence

    • Many of our interviewees found it easier to articulate the surface-level challenges they faced, while struggling to convey the nuanced experiences of their deeper suffering.
    • In part, this may be because our society lacks the appropriate vocabulary to capture such profound and wide-ranging pain.
    • She felt there was “no point really talking about it as I could tell it’s upsetting for people to hear”.
    • John, 63, said he found it challenging to communicate his “hidden disability” and associated suffering because he was “not in a wheelchair” and didn’t have “a plaster cast on my hand”.
    • I had already taken a six-week sicknote and couldn’t take any more, because my financial position was very weak.

We need to talk about existential concerns

    • When considering coping strategies, we believe it is essential to promote a better understanding of the prevalence of existential crisis among society as a whole.
    • Not everyone, of course, can access highly specialised support such as existential therapy, which can be a useful tool for confronting existential dilemmas and gaining insight into values and beliefs.
    • What’s needed is a more accessible way to directly address and discuss our existential worries.
    • A European research project has created a programme to help healthcare professionals engage in existential conversations more sensitively and confidently.
    • *All names have been anonymised to protect the interviewees’ identities For you: more from our Insights series:
    • Chao Fang received funding from UKRI and NIHR (COV-LT-0009) for the study reported in this article.
    • JD Carpentieri received funding from UKRI and NIHR (COV-LT-0009) for the study reported in this article.

Eureka Health Launches with $7 million For Patient-Led Platform To Share and Discover Better Treatments

Retrieved on: 
Wednesday, July 12, 2023

SAN MATEO, Calif., July 12, 2023 /PRNewswire-PRWeb/ -- Eureka Health, a new community dedicated to helping chronic disease patients share experiences and discover the latest treatments, launched today to provide hope to people living with chronic diseases. Emerging from stealth with thousands already engaged in its Long Covid group, the AI-powered platform added metabolic disease, autoimmune disorders, ME/CFS, and related conditions. It will expand into other conditions in the coming weeks.

Key Points: 
  • Emerging from stealth with thousands already engaged in its Long Covid group, the AI-powered platform added metabolic disease, autoimmune disorders, ME/CFS, and related conditions.
  • Funds will be used to build and grow the community, expand its treatment database, and ultimately influence and advance treatment research.
  • Drawing on their deep backgrounds in engineering and product development, as well as their personal experiences, the Eureka platform came to life.
  • "With Eureka, patients have a platform to exchange data and rare experiences with others, giving them a community in times when they need it the most."

Freedom From Fibromyalgia Summit to Take Place Virtually on May 23rd-30th, 2023

Retrieved on: 
Thursday, April 27, 2023

CARLSBAD, Calif., April 27, 2023 /PRNewswire/ -- DrTalks is thrilled to announce the Freedom From Fibromyalgia Summit .

Key Points: 
  • CARLSBAD, Calif., April 27, 2023 /PRNewswire/ -- DrTalks is thrilled to announce the Freedom From Fibromyalgia Summit .
  • Taking place from May 23-30, 2023, this online summit is designed to help millions of people around the world who are suffering from fibromyalgia.
  • At the Freedom From Fibromyalgia Summit , you will learn how to take control of your health and live a life free of fibromyalgia.
  • Join him and his team of experts at the Freedom From Fibromyalgia Summit to learn how to take control of your life.

Metrodora Institute Launches to Advance the Treatment of Complex Neuroimmune Diseases and Accelerate the Path to Cures

Retrieved on: 
Wednesday, April 19, 2023

SALT LAKE CITY, April 19, 2023 /PRNewswire/ -- The Metrodora Institute today announced the opening of its state-of-the-art medical and research center, dedicated to advancing care and accelerating the path to improved diagnostics, therapeutics, and cures for patients living with neuroimmune axis disorders. The opening follows a soft launch that welcomed initial patients over the last month. Located in Salt Lake City, UT, the multidisciplinary institute brings together world-class clinicians, scientists, and engineers under one roof to maximize the impact of scientific discovery and rapidly translate research into better patient outcomes. Metrodora is designed to deliver a new blueprint for healthcare that breaks down the barriers between medical specialties and embeds scientific research and discovery directly into the patient care process. The Metrodora Foundation, the Institute's non-profit research arm, will fund and further the scientific discovery needed to accelerate novel treatments and cures.

Key Points: 
  • The Metrodora Foundation, the Institute's non-profit research arm, will fund and further the scientific discovery needed to accelerate novel treatments and cures.
  • Neuroimmune axis disorders are complex chronic illnesses that trigger dysfunctional interactions across multiple body systems, including the nervous, immune, endocrine, and gastrointestinal systems.
  • "In order to improve the lives of people living with neuroimmune axis disorders, we must accelerate progress towards treatments and cures.
  • The Metrodora Institute is bridging these gaps in care by redefining how research and clinical practice work together to treat and cure complex, chronic diseases.